Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3

P. Bojarová, MR. Tavares, D. Laaf, L. Bumba, L. Petrásková, R. Konefał, M. Bláhová, H. Pelantová, L. Elling, T. Etrych, P. Chytil, V. Křen,

. 2018 ; 16 (1) : 73. [pub] 20180920

Language English Country England, Great Britain

Document type Journal Article

BACKGROUND: Galectin-3 (Gal-3) is a promising target in cancer therapy with a high therapeutic potential due to its abundant localization within the tumor tissue and its involvement in tumor development and proliferation. Potential clinical application of Gal-3-targeted inhibitors is often complicated by their insufficient selectivity or low biocompatibility. Nanomaterials based on N-(2-hydroxypropyl)methacrylamide (HPMA) nanocarrier are attractive for in vivo application due to their good water solubility and lack of toxicity and immunogenicity. Their conjugation with tailored carbohydrate ligands can yield specific glyconanomaterials applicable for targeting biomedicinally relevant lectins like Gal-3. RESULTS: In the present study we describe the synthesis and the structure-affinity relationship study of novel Gal-3-targeted glyconanomaterials, based on hydrophilic HPMA nanocarriers. HPMA nanocarriers decorated with varying amounts of Gal-3 specific epitope GalNAcβ1,4GlcNAc (LacdiNAc) were analyzed in a competitive ELISA-type assay and their binding kinetics was described by surface plasmon resonance. We showed the impact of various linker types and epitope distribution on the binding affinity to Gal-3. The synthesis of specific functionalized LacdiNAc epitopes was accomplished under the catalysis by mutant β-N-acetylhexosaminidases. The glycans were conjugated to statistic HPMA copolymer precursors through diverse linkers in a defined pattern and density using Cu(I)-catalyzed azide-alkyne cycloaddition. The resulting water-soluble and structurally flexible synthetic glyconanomaterials exhibited affinity to Gal-3 in low μM range. CONCLUSIONS: The results of this study reveal the relation between the linker structure, glycan distribution and the affinity of the glycopolymer nanomaterial to Gal-3. They pave the way to specific biomedicinal glyconanomaterials that target Gal-3 as a therapeutic goal in cancerogenesis and other disorders.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19000359
003      
CZ-PrNML
005      
20190111150246.0
007      
ta
008      
190107s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12951-018-0399-1 $2 doi
035    __
$a (PubMed)30236114
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bojarová, P $u Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 14220, Prague 4, Czech Republic. bojarova@biomed.cas.cz.
245    10
$a Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3 / $c P. Bojarová, MR. Tavares, D. Laaf, L. Bumba, L. Petrásková, R. Konefał, M. Bláhová, H. Pelantová, L. Elling, T. Etrych, P. Chytil, V. Křen,
520    9_
$a BACKGROUND: Galectin-3 (Gal-3) is a promising target in cancer therapy with a high therapeutic potential due to its abundant localization within the tumor tissue and its involvement in tumor development and proliferation. Potential clinical application of Gal-3-targeted inhibitors is often complicated by their insufficient selectivity or low biocompatibility. Nanomaterials based on N-(2-hydroxypropyl)methacrylamide (HPMA) nanocarrier are attractive for in vivo application due to their good water solubility and lack of toxicity and immunogenicity. Their conjugation with tailored carbohydrate ligands can yield specific glyconanomaterials applicable for targeting biomedicinally relevant lectins like Gal-3. RESULTS: In the present study we describe the synthesis and the structure-affinity relationship study of novel Gal-3-targeted glyconanomaterials, based on hydrophilic HPMA nanocarriers. HPMA nanocarriers decorated with varying amounts of Gal-3 specific epitope GalNAcβ1,4GlcNAc (LacdiNAc) were analyzed in a competitive ELISA-type assay and their binding kinetics was described by surface plasmon resonance. We showed the impact of various linker types and epitope distribution on the binding affinity to Gal-3. The synthesis of specific functionalized LacdiNAc epitopes was accomplished under the catalysis by mutant β-N-acetylhexosaminidases. The glycans were conjugated to statistic HPMA copolymer precursors through diverse linkers in a defined pattern and density using Cu(I)-catalyzed azide-alkyne cycloaddition. The resulting water-soluble and structurally flexible synthetic glyconanomaterials exhibited affinity to Gal-3 in low μM range. CONCLUSIONS: The results of this study reveal the relation between the linker structure, glycan distribution and the affinity of the glycopolymer nanomaterial to Gal-3. They pave the way to specific biomedicinal glyconanomaterials that target Gal-3 as a therapeutic goal in cancerogenesis and other disorders.
650    _2
$a akrylamidy $x chemie $x metabolismus $7 D000178
650    _2
$a nosiče léků $x chemie $x metabolismus $7 D004337
650    12
$a lékové transportní systémy $7 D016503
650    _2
$a galektin 3 $x metabolismus $7 D037502
650    _2
$a glykokonjugáty $x chemie $x metabolismus $7 D006001
650    _2
$a lidé $7 D006801
650    _2
$a nanostruktury $x chemie $7 D049329
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tavares, M R $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovský Sq. 2, 16206, Prague 6, Czech Republic.
700    1_
$a Laaf, D $u Laboratory for Biomaterials, Institute for Biotechnology and Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstraße 20, 52074, Aachen, Germany.
700    1_
$a Bumba, L $u Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 14220, Prague 4, Czech Republic.
700    1_
$a Petrásková, L $u Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 14220, Prague 4, Czech Republic.
700    1_
$a Konefał, R $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovský Sq. 2, 16206, Prague 6, Czech Republic.
700    1_
$a Bláhová, M $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovský Sq. 2, 16206, Prague 6, Czech Republic.
700    1_
$a Pelantová, H $u Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 14220, Prague 4, Czech Republic.
700    1_
$a Elling, L $u Laboratory for Biomaterials, Institute for Biotechnology and Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstraße 20, 52074, Aachen, Germany.
700    1_
$a Etrych, T $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovský Sq. 2, 16206, Prague 6, Czech Republic.
700    1_
$a Chytil, P $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovský Sq. 2, 16206, Prague 6, Czech Republic. chytil@imc.cas.cz.
700    1_
$a Křen, V $u Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 14220, Prague 4, Czech Republic.
773    0_
$w MED00008237 $t Journal of nanobiotechnology $x 1477-3155 $g Roč. 16, č. 1 (2018), s. 73
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30236114 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190111150451 $b ABA008
999    __
$a ok $b bmc $g 1364465 $s 1038482
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 16 $c 1 $d 73 $e 20180920 $i 1477-3155 $m Journal of nanobiotechnology $n J Nanobiotechnology $x MED00008237
LZP    __
$a Pubmed-20190107

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...